InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

REPLIGEN CORP

RGEN Clue Score51
United States Fiscal year ends December CIK 0000730272 Results filed 27 Oct 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

27
Insider
Date
Role
Action
Shares
Price
Amount
Olivier Loeillot
5 Oct 2026
Chief Executive Officer
Sold after exercise
4,202
$190.00
$798.38K
Olivier Loeillot
5 Oct 2026
Chief Executive Officer
Sold after exercise
1,333
$178.75
$238.27K
Olivier Loeillot
24 Sep 2026
Chief Executive Officer
Sold after exercise
4,542
$190.00
$862.98K
Olivier Loeillot
24 Sep 2026
Chief Executive Officer
Sold after exercise
8,404
$190.00
$1.60M
Olivier Loeillot
21 Sep 2026
Chief Executive Officer
Sold after exercise
5,426
$180.00
$976.68K
Olivier Loeillot
4 Sep 2026
Chief Executive Officer
Sold on a plan
3,035
$165.90
$503.51K
Olivier Loeillot
20 Aug 2026
Chief Executive Officer
Sold after exercise
5,426
$180.00
$976.68K
Jason K Garland
16 Jul 2026
CFO
Sold on a plan
530
$150.00
$79.50K
Jason K Garland
25 Jun 2026
CFO
Sold on a plan
733
$145.00
$106.29K
Glenn P Muir
7 May 2026
Director
Exercised, kept
2,434
$38.76
$94.34K
Olivier Loeillot
21 Apr 2026
Chief Executive Officer
Sold on a plan
3,832
$140.00
$536.48K
Karen A Dawes
17 Dec 2025
Director
Sell
275
$161.00
$44.28K
Glenn P Muir
16 Dec 2025
Director
Exercised, kept
3,366
$26.12
$87.92K
Olivier Loeillot
25 Nov 2025
Chief Executive Officer
Sold on a plan
7,041
$170.00
$1.20M
James Bylund
18 Nov 2025
Chief Operating Officer
Sell
2,191
$151.21
$331.30K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
1,956
$157.11
$307.31K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
5,737
$156.22
$896.23K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
3,000
$155.45
$466.35K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
2,500
$154.32
$385.80K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
2,923
$153.14
$447.63K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
2,100
$152.17
$319.56K
Anthony Hunt
13 Nov 2025
Director
Sold after exercise
1,784
$151.01
$269.40K
Anthony Hunt
12 Nov 2025
Director
Sold after exercise
464
$158.51
$73.55K
Anthony Hunt
12 Nov 2025
Director
Sold after exercise
11,096
$158.01
$1.75M
Anthony Hunt
12 Nov 2025
Director
Sold after exercise
4,959
$156.65
$776.83K
Anthony Hunt
12 Nov 2025
Director
Sold after exercise
4,740
$155.85
$738.73K
Anthony Hunt
12 Nov 2025
Director
Sold after exercise
3,741
$154.92
$579.56K

What was left out

Form 4 filings counted 42
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 18
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 145,954
History held since 6 Dec 2006